Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms

被引:355
作者
Borriello, G
Werner, E
Roe, F
Kim, AM
Ehrlich, GD
Stewart, PS [1 ]
机构
[1] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA
[2] Montana State Univ, Dept Chem Engn, Bozeman, MT 59717 USA
[3] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA
关键词
D O I
10.1128/AAC.48.7.2659-2664.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of oxygen limitation in protecting Pseudomonas aeruginosa strains growing in biofilms from killing by antibiotics was investigated in vitro. Bacteria in mature (48-h-old) colony biofilms were poorly killed when they were exposed to tobramycin, ciprofloxacin, carbenicillin, ceftazidime, chloramphenicol, or tetracycline for 12 h. It was shown with oxygen microelectrodes that these biofilms contain large anoxic regions. Oxygen penetrated about 50 mum into the biofilms, which averaged 210 mum thick. The region of active protein synthesis was visualized by using an inducible green fluorescent protein. This zone was also limited to a narrow band, approximately 30 mum wide, adjacent to the air interface of the biofilm. The bacteria in mature biofilms exhibited a specific growth rate of only 0.02 h(-1). These results show that 48-h-old colony biofilms are physiologically heterogeneous and that most of the cells in the biofilm occupy an oxygen-limited, stationary-phase state. In contrast, bacteria in 4-h-old colony biofilms were still growing, active, and susceptible to antibiotics when they were challenged in air. When 4-h-old colony biofilms were challenged under anaerobic conditions, the level of killing by antibiotics was reduced compared to that for the controls grown aerobically. Oxygen limitation could explain 70% or more of the protection afforded to 48-h-old colony biofilms for all antibiotics tested. Nitrate amendment stimulated the growth of untreated control P. aeruginosa isolates grown under anaerobic conditions but decreased the susceptibilities of the organisms to antibiotics. Local oxygen limitation and the presence of nitrate may contribute to the reduced susceptibilities of P. aeruginosa biofilms causing infections in vivo.
引用
收藏
页码:2659 / 2664
页数:6
相关论文
共 25 条
[1]   Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin [J].
Anderl, JN ;
Franklin, MJ ;
Stewart, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1818-1824
[2]   Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal β-lactamase [J].
Bagge, N ;
Ciofu, O ;
Skovgaard, LT ;
Hoiby, N .
APMIS, 2000, 108 (09) :589-600
[3]   RESISTANCE OF BACTERIAL BIOFILMS TO ANTIBIOTICS - A GROWTH-RATE RELATED EFFECT [J].
BROWN, MRW ;
ALLISON, DG ;
GILBERT, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :777-780
[4]   EFFECT OF THE ABSCESS ENVIRONMENT ON THE ANTIMICROBIAL ACTIVITY OF CIPROFLOXACIN [J].
BRYANT, RE ;
MAZZA, JA .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A) :S23-S27
[5]   COMPARISON OF DENITRIFICATION BY PSEUDOMONAS-STUTZERI, PSEUDOMONAS-AERUGINOSA, AND PARACOCCUS-DENITRIFICANS [J].
CARLSON, CA ;
INGRAHAM, JL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1983, 45 (04) :1247-1253
[6]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[7]   TOLERANCE OF PSEUDOMONAS-AERUGINOSA TO KILLING BY CIPROFLOXACIN, GENTAMICIN AND IMIPENEM INVITRO AND INVIVO [J].
DAVEY, P ;
BARZA, M ;
STUART, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (04) :395-404
[8]   Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation [J].
Drenkard, E ;
Ausubel, FM .
NATURE, 2002, 416 (6882) :740-743
[9]   SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA AND ESCHERICHIA-COLI BIOFILMS TOWARDS CIPROFLOXACIN - EFFECT OF SPECIFIC GROWTH-RATE [J].
EVANS, DJ ;
ALLISON, DG ;
BROWN, MRW ;
GILBERT, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :177-184
[10]   Nitric oxide metabolites in cystic fibrosis lung disease [J].
Grasemann, H ;
Ioannidis, I ;
Tomkiewicz, RP ;
de Groot, H ;
Rubin, BK ;
Ratjen, F .
ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 78 (01) :49-53